Frontiers in medicine · 2026
Evaluation of a new droplet digital PCR for diagnosis of pulmonary tuberculosis and tuberculous pleurisy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ou Xichao, Zheng Huiwen, Bao Xundi, Hu Peilei, Liu Zhou, Guo Jingwei, Xu Dongfang, Li Yue, Li Jingjing, Zhao Bing, Kang Jie, Ma Qi, Xia Hui, Tan Yunhong, Zhao Yanlin
Аннотация
INTRODUCTION: Digital droplet PCR (ddPCR) offers high sensitivity and absolute quantification without standard curves, making it promising for tuberculosis (TB) detection in paucibacillary samples. This study evaluated the diagnostic performance of a ddPCR assay targeting IS6110 and 23S rRNA for pulmonary tuberculosis (PTB) and tuberculous pleurisy (TP).
METHODS: A total of 436 patients (245 suspected PTB, 191 suspected TP) were prospectively enrolled. ddPCR was performed on sputum, bronchoalveolar lavage fluid, and pleural effusion samples. Diagnostic performance was compared with Xpert MTB/RIF and culture.
RESULTS: In suspected PTB, ddPCR showed significantly higher sensitivity than Xpert (49.70% vs. 38.10%, p < 0.001), while Xpert showed higher specificity (98.65% vs. 87.70%). In suspected TP, ddPCR also demonstrated superior sensitivity (17.54% vs. 10.40%, p < 0.001). For NTM detection, ddPCR achieved 60% sensitivity and 99.58% specificity.
DISCUSSION: ddPCR offers improved sensitivity for PTB and TP diagnosis, particularly in paucibacillary cases, though its lower specificity necessitates confirmatory testing. The dual-target design enables simultaneous MTB/NTM differentiation, providing clinical utility for guiding appropriate therapy.
METHODS: A total of 436 patients (245 suspected PTB, 191 suspected TP) were prospectively enrolled. ddPCR was performed on sputum, bronchoalveolar lavage fluid, and pleural effusion samples. Diagnostic performance was compared with Xpert MTB/RIF and culture.
RESULTS: In suspected PTB, ddPCR showed significantly higher sensitivity than Xpert (49.70% vs. 38.10%, p < 0.001), while Xpert showed higher specificity (98.65% vs. 87.70%). In suspected TP, ddPCR also demonstrated superior sensitivity (17.54% vs. 10.40%, p < 0.001). For NTM detection, ddPCR achieved 60% sensitivity and 99.58% specificity.
DISCUSSION: ddPCR offers improved sensitivity for PTB and TP diagnosis, particularly in paucibacillary cases, though its lower specificity necessitates confirmatory testing. The dual-target design enables simultaneous MTB/NTM differentiation, providing clinical utility for guiding appropriate therapy.